🇺🇸 Dengue Tetravalent Vaccine, Live in United States

Dengue Tetravalent Vaccine, Live (Dengue Tetravalent Vaccine, Live) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Dengue Tetravalent Vaccine, Live in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Dengue Tetravalent Vaccine, Live approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Dengue Tetravalent Vaccine, Live in United States?

Sanofi Pasteur, a Sanofi Company is the originator. The local marketing authorisation holder may differ — check the official source linked above.